Cases & Deals

Guided Therapeutics issues $3 million of Senior Convertible Notes in private placement

Client(s) Guided Therapeutics, Inc.

Jones Day advised Guided Therapeutics, Inc., a medical device company developing a biophotonic cancer detection testing platform, in connection with its issuance of $3 million in aggregate principal amount of 6% Senior Convertible Notes in a private placement to an institutional investor.